EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Supply-Chain Disruption, Supplier-Country Health, and the Reallocation of US Import-Value Shares: Monthly Evidence Under Timing-Disciplined Measurement

Shawn McCarthy, Gita Alaghband

Economies · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Supply-chain disruptions since 2018 renewed attention to supplier-country conditions; this paper examines whether deterioration in those conditions precedes changes in US import-value shares when each measure is dated to match the question asked. From 564,983 deduplicated news records (2018–2026) and direct-source IMF, COMTRADE, and BIS data for 62 supplier economies, we build a Country Health Score under two datings: reference-dated, assigned to the months the data describe, and availability-lagged, shifted by one-to-three-month frontier-lag proxies. Among 29 dominant commodity–country cells across 14 countries, reference-dated deterioration is followed by within-commodity share erosion over three to twelve months, concentrated after 2022 and surviving Holm and wild-cluster inference at every horizon (largest Holm or wild-cluster p=0.014). Excluding Canada and Mexico, the association is solid at three months and suggestive at six. The association survives a pre-specified mechanical-channel gate (re-estimation without the export-coverage component) and a timing placebo; conflict-coverage spikes are a second, timelier predictor (post hoc). The same regression on the availability-lagged composite is null, and the corresponding coefficients differ formally at three and six months, consistent with timing-misalignment attenuation. Return regressions delimit rather than support the claim: no predictive relationship replicates out of sample. These results document a timing-consistent association, not an identified causal effect. Observations postdating the frozen analysis plan will provide the first fully prospective test.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Shawn McCarthy, Gita Alaghband
Quelle
Economies
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
2227-7099
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Shawn McCarthy, Gita Alaghband (2026). Supply-Chain Disruption, Supplier-Country Health, and the Reallocation of US Import-Value Shares: Monthly Evidence Under Timing-Disciplined Measurement. Economies. https://doi.org/10.3390/economies14090395
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1